77 related articles for article (PubMed ID: 9061687)
1. Prion protein immunocytochemistry--UK five centre consensus report.
Bell JE; Gentleman SM; Ironside JW; McCardle L; Lantos PL; Doey L; Lowe J; Fergusson J; Luthert P; McQuaid S; Allen IV
Neuropathol Appl Neurobiol; 1997 Feb; 23(1):26-35. PubMed ID: 9061687
[TBL] [Abstract][Full Text] [Related]
2. Abnormal isoform of prion proteins accumulates in the synaptic structures of the central nervous system in patients with Creutzfeldt-Jakob disease.
Kitamoto T; Shin RW; Doh-ura K; Tomokane N; Miyazono M; Muramoto T; Tateishi J
Am J Pathol; 1992 Jun; 140(6):1285-94. PubMed ID: 1351366
[TBL] [Abstract][Full Text] [Related]
3. Advances in the detection of prion protein in peripheral tissues of variant Creutzfeldt-Jakob disease patients using paraffin-embedded tissue blotting.
Ritchie DL; Head MW; Ironside JW
Neuropathol Appl Neurobiol; 2004 Aug; 30(4):360-8. PubMed ID: 15305981
[TBL] [Abstract][Full Text] [Related]
4. [Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies. Part II].
Zaborowski A
Psychiatr Pol; 2004; 38(2):297-309. PubMed ID: 15307294
[TBL] [Abstract][Full Text] [Related]
5. Amyloid plaques in Creutzfeldt-Jakob disease stain with prion protein antibodies.
Kitamoto T; Tateishi J; Tashima T; Takeshita I; Barry RA; DeArmond SJ; Prusiner SB
Ann Neurol; 1986 Aug; 20(2):204-8. PubMed ID: 3092727
[TBL] [Abstract][Full Text] [Related]
6. The epsilon isoform of 14-3-3 protein is a component of the prion protein amyloid deposits of Gerstmann-Sträussler-Scheinker disease.
Di Fede G; Giaccone G; Limido L; Mangieri M; Suardi S; Puoti G; Morbin M; Mazzoleni G; Ghetti B; Tagliavini F
J Neuropathol Exp Neurol; 2007 Feb; 66(2):124-30. PubMed ID: 17278997
[TBL] [Abstract][Full Text] [Related]
7. Distinctive cerebellar immunoreactivity for the prion protein in familial (E200K) Creutzfeldt-Jakob disease.
Jarius C; Kovacs GG; Belay G; Hainfellner JA; Mitrova E; Budka H
Acta Neuropathol; 2003 May; 105(5):449-54. PubMed ID: 12677444
[TBL] [Abstract][Full Text] [Related]
8. Prion protein immunocytochemistry: reliable protocols for the investigation of Creutzfeldt-Jakob disease.
Hayward PA; Bell JE; Ironside JW
Neuropathol Appl Neurobiol; 1994 Aug; 20(4):375-83. PubMed ID: 7808588
[TBL] [Abstract][Full Text] [Related]
9. Clusterin solubility and aggregation in Creutzfeldt-Jakob disease.
Freixes M; Puig B; Rodríguez A; Torrejón-Escribano B; Blanco R; Ferrer I
Acta Neuropathol; 2004 Oct; 108(4):295-301. PubMed ID: 15235804
[TBL] [Abstract][Full Text] [Related]
10. The sequential development of abnormal prion protein accumulation in mice with Creutzfeldt-Jakob disease.
Muramoto T; Kitamoto T; Tateishi J; Goto I
Am J Pathol; 1992 Jun; 140(6):1411-20. PubMed ID: 1376559
[TBL] [Abstract][Full Text] [Related]
11. Characterisation of new monoclonal antibodies reacting with prions from both human and animal brain tissues.
Cordes H; Bergström AL; Ohm J; Laursen H; Heegaard PM
J Immunol Methods; 2008 Sep; 337(2):106-20. PubMed ID: 18657541
[TBL] [Abstract][Full Text] [Related]
12. Cerebral amyloid angiopathy with co-localization of prion protein and beta-amyloid in an 85-year-old patient with sporadic Creutzfeldt-Jakob disease.
Paquet C; Privat N; Kaci R; Polivka M; Dupont O; Haïk S; Laplanche JL; Hauw JJ; Gray F
Acta Neuropathol; 2008 Nov; 116(5):567-73. PubMed ID: 18551298
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of water channel aquaporin 1 and aquaporin 4 in Creutzfeldt-Jakob disease and in bovine spongiform encephalopathy-infected bovine-PrP transgenic mice.
Rodríguez A; Pérez-Gracia E; Espinosa JC; Pumarola M; Torres JM; Ferrer I
Acta Neuropathol; 2006 Nov; 112(5):573-85. PubMed ID: 16871401
[TBL] [Abstract][Full Text] [Related]
14. Loss of cerebellar granule neurons is associated with punctate but not with large focal deposits of prion protein in Creutzfeldt-Jakob disease.
Faucheux BA; Privat N; Brandel JP; Sazdovitch V; Laplanche JL; Maurage CA; Hauw JJ; Haïk S
J Neuropathol Exp Neurol; 2009 Aug; 68(8):892-901. PubMed ID: 19606064
[TBL] [Abstract][Full Text] [Related]
15. Variant Creutzfeldt-Jakob disease: immunocytochemical studies and image analysis.
Nailon WH; Ironside JW
Microsc Res Tech; 2000 Jul; 50(1):2-9. PubMed ID: 10871542
[TBL] [Abstract][Full Text] [Related]
16. Adenosine A1 receptor protein levels and activity is increased in the cerebral cortex in Creutzfeldt-Jakob disease and in bovine spongiform encephalopathy-infected bovine-PrP mice.
Rodríguez A; Martín M; Albasanz JL; Barrachina M; Espinosa JC; Torres JM; Ferrer I
J Neuropathol Exp Neurol; 2006 Oct; 65(10):964-75. PubMed ID: 17021401
[TBL] [Abstract][Full Text] [Related]
17. Species-specificity of a panel of prion protein antibodies for the immunohistochemical study of animal and human prion diseases.
Furuoka H; Yabuzoe A; Horiuchi M; Tagawa Y; Yokoyama T; Yamakawa Y; Shinagawa M; Sata T
J Comp Pathol; 2007 Jan; 136(1):9-17. PubMed ID: 17270205
[TBL] [Abstract][Full Text] [Related]
18. Different prion conformers target the olfactory pathway in sporadic Creutzfeldt-Jakob disease.
Zanusso G; Ferrari S; Benedetti D; Sbriccoli M; Rizzuto N; Monaco S
Ann N Y Acad Sci; 2009 Jul; 1170():637-43. PubMed ID: 19686205
[TBL] [Abstract][Full Text] [Related]
19. Plaque-type deposition of prion protein in the damaged white matter of sporadic Creutzfeldt-Jakob disease MM1 patients.
Kobayashi A; Arima K; Ogawa M; Murata M; Fukuda T; Kitamoto T
Acta Neuropathol; 2008 Nov; 116(5):561-6. PubMed ID: 18751990
[TBL] [Abstract][Full Text] [Related]
20. Objective quantification of prion protein in spinal cords of cases of Creutzfeldt-Jakob disease.
Sutherland K; Goodbrand IA; Bell JE; Ironside JW
Anal Cell Pathol; 1996 Jan; 10(1):25-35. PubMed ID: 8789267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]